“I would hope that something positive will come out of this study so that lives may be saved or at least [that] it may lead to a vaccine... that will help fight the disease.”
—Volunteer
Are you interested in learning about other Clinical Trials at Vanderbilt? Click Here to learn more about a variety of research opportunities!
Current Studies
HVTN 077
- Approximately 192 participants will be enrolled network-wide.
- Phase 1 (approximately 22 people will be enrolled at our site).
- The purpose of this study is to evaluate the safety and immune response to the DNA vaccine prime with an Adenovirus 5 or Adenovirus 35 boost.
- It is impossible to get HIV from participating in a trial. There is no HIV in the vaccines.
HVTN 205
- Approximately 225 participants will be enrolled network-wide.
- Phase 2 (approximately 28 people will be enrolled at our site).
- Participants in this study can not have had a smallpox vaccine previously.
- The purpose of this study is to evaluate the safety and immune response to the DNA vaccine prime in combination with an MVA boost.
- It is impossible to get HIV from participating in a trial. There is no HIV in the vaccines.